Sean Wuxiong Cao Sells $79.9K of NovaBridge Biosciences (NBP) — SEC Form 4, Sep 11, 2026

Open-Market Net Sale · SEC Form 4
−$79,904

Equity position changed by -28.8%

Reporting Owner
TXN 2026-09-09 · FILED 2026-09-11
Equity Position 266K sh 374,445 → 266,467
Equity Change -28.8% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-09-11
Report Date
2026-09-11
Accession No.
0002109966-26-000008
Accepted At
2026-09-11 20:30 UTC
Reporting Owner
Name Relationship
Sean Wuxiong Cao CIK 0002109966
Officer
Sean Wuxiong Cao at NovaBridge Biosciences Full insider history
Bought (12 mo) —
Sold (12 mo) $122,488
More from this insider at NovaBridge Biosciences
2026-09-08 Exercise — View
2026-06-24 Award — View
2026-05-18 Sell -$42,584 View
All filings by this insider at NovaBridge Biosciences
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Ordinary SharesF1F2F3F4 2026-09-09 S - Sale 107,978 D $0.74 -$79,904 266,467 Direct
Footnotes (4)
F1
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. Show more
F2
The Reporting Person sold 46,947 ADSs representing approximately 107,978 ordinary shares in connection with the partial vesting of a restricted stock unit award on September 3, 2026, solely to satisfy tax withholding obligations incurred in connection with the vesting. Show more
F3
Reported securities are represented by 46,947 ADSs. Show more
F4
Reported sales price represents the converted sales price of the ADSs of $1.6908. Show more
5%+ Holders · 13D/G 3 filers
Other insiders at NovaBridge Biosciences
All NovaBridge Biosciences insider activity
GET /v1/forms/4/0002109966-26-000008 API docs
View Original SEC Filing